GlaxoSmithKline S.A.E Market Cap

GlaxoSmithKline S.A.E has a market cap or net worth of 3.18 billion as of June 27, 2025. Its market cap has increased by 31.57% in one year.

Market Cap

3.18B

Enterprise Value

3.04B

Revenue

3.27B

Ranking

n/a

PE Ratio

13.15

Stock Price

38.13

Market Cap Chart

Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.18B, an increase of 459.20%. That is a compound annual growth rate of 9.06%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2025	3.18B	5.92%
Dec 31, 2024	3.01B	1.27%
Dec 31, 2023	2.97B	-6.84%
Dec 29, 2022	3.19B	23.58%
Dec 30, 2021	2.58B	82.08%
Dec 31, 2020	1.42B	-14.17%
Dec 31, 2019	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Commercial International Bank Egypt (CIB) S.A.E.	255.32B
El Sewedy Electric Company	159.49B
Talaat Moustafa Group Holding	114.79B
Eastern Company S.A.E	91.50B
Misr Fertilizer Production Company	70.71B
Alexandria Container&Cargo Handling Company	66.80B
Egypt Aluminum	64.73B
Telecom Egypt Company	61.52B

Market Cap Rankings